Jazz Pharmaceuticals (JAZZ) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 588.19% |
| Dec 31, 2025 | -51.62% |
| Sep 30, 2025 | 120.10% |
| Jun 30, 2025 | -22.42% |
| Mar 31, 2025 | -380.53% |
| Dec 31, 2024 | -77.07% |
| Sep 30, 2024 | 1,089.66% |
| Jun 30, 2024 | -41.81% |
| Mar 31, 2024 | -136.27% |
| Dec 31, 2023 | 210.33% |
| Sep 30, 2023 | -52.43% |
| Jun 30, 2023 | -60.03% |
| Mar 31, 2023 | 669.31% |
| Dec 31, 2022 | -72.15% |
| Sep 30, 2022 | -40.56% |
| Jun 30, 2022 | 326.64% |
| Mar 31, 2022 | -25.56% |
| Dec 31, 2021 | 63.78% |
| Sep 30, 2021 | 81.94% |
| Jun 30, 2021 | -215.98% |
| Mar 31, 2021 | 229.90% |
| Dec 31, 2020 | 810.11% |
| Sep 30, 2020 | -152.94% |
| Jun 30, 2020 | 28.65% |
| Mar 31, 2020 | 141.00% |
| Dec 31, 2019 | -200.41% |
| Sep 30, 2019 | 75.87% |
| Jun 30, 2019 | -62.15% |
| Mar 31, 2019 | 226.33% |
| Dec 31, 2018 | -1,295.46% |
| Sep 30, 2018 | -47.93% |
| Jun 30, 2018 | -55.26% |
| Mar 31, 2018 | -49.03% |
| Dec 31, 2017 | 954.99% |
| Sep 30, 2017 | 111.48% |
| Jun 30, 2017 | -428.98% |
| Mar 31, 2017 | -404.93% |
| Dec 31, 2016 | 101.35% |
| Sep 30, 2016 | -361.32% |
| Jun 30, 2016 | -751.54% |
| Mar 31, 2016 | -70.95% |
| Dec 31, 2015 | -109.92% |
| Sep 30, 2015 | -44.40% |
| Jun 30, 2015 | 21.67% |
| Mar 31, 2015 | 1.77% |
| Dec 31, 2014 | -64.61% |
| Sep 30, 2014 | 1,287.11% |
| Jun 30, 2014 | 105.72% |
| Sep 30, 2013 | 68.73% |
| Jun 30, 2013 | 79.01% |
| Mar 31, 2013 | -65.88% |
| Dec 31, 2012 | 459.00% |
| Sep 30, 2012 | 323.47% |
| Jun 30, 2012 | -117.63% |
| Mar 31, 2012 | 562.81% |
| Dec 31, 2011 | -1,520.58% |
| Sep 30, 2011 | -103.16% |
| Jun 30, 2011 | 84.22% |
| Mar 31, 2011 | -7.63% |
| Dec 31, 2010 | 65.23% |